Ospedale Civico, Lugano   Report issue

Academic/Hospital Phase 4
Founded: Lugano Switzerland (1909)

Organization Overview

First Clinical Trial
2009
NCT01245777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Claudio Gobbi | Neurocenter of Southern Switzerland, Ospedale Civico Lugano | Neuroenter of Southern Switzerland, Ospedale Civico, Lugano

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Multiple Sclerosis (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 4)

Psychomotor Agitation (Phase 4)

Restless Legs Syndrome (Phase 4)

Sclerosis (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4